---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-046849"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2024-11-19T23:59:59+00:00"
generated_at: "2026-05-29T22:41:31.066582+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharma appoints director Fry (420K options); amends CFO pay (£400K, 40% bonus) and quorum rule

## Summary
- Simon Fry appointed as director effective Dec 18, 2024; receives initial option for 420,000 common shares.
- CFO James Bligh's employment amendment: £400K base salary, discretionary bonus up to 40%, 6-month notice.
- Bylaws amended: quorum reduced from majority to one-third voting power, effective after 2024 annual meeting.

## SEC filing metadata
- accession: 0001493152-24-046849
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2024-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/0001493152-24-046849-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-046849
- JSON: https://secwatch.observer/filing/0001493152-24-046849.json
- Plain text: https://secwatch.observer/filing/0001493152-24-046849.txt

## Source-grounded claims
- claim_id: 9f4142d9a2
  claim: Simon Fry was appointed as director at CDT Equity Inc..
  evidence_excerpt: the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/0001493152-24-046849-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.